TIP20 Activators
TIP20 can influence its function in vesicular transport and membrane fusion by modulating the intracellular levels of cyclic AMP (cAMP), an essential second messenger in cellular signaling pathways. Forskolin, for example, directly stimulates adenylate cyclase, the enzyme responsible for converting ATP to cAMP, thereby raising cAMP levels and enhancing TIP20 activity in the secretory pathway. Similarly, IBMX acts to maintain elevated levels of cAMP by inhibiting phosphodiesterases, the enzymes that degrade cAMP, thus supporting the sustained activity of TIP20 in vesicular trafficking. Epinephrine and Salbutamol, through their action on adrenergic receptors, and Dopamine, via D1-like receptors, also trigger adenylate cyclase to produce more cAMP, which in turn can promote TIP20's role in the docking and fusion of vesicles.
Additionally, PGE2, by interacting with its own G-protein-coupled receptors, and Histamine, through its H2 receptors, initiate a cascade that leads to cAMP accumulation, which can further facilitate TIP20's involvement in vesicular transport. Cholera toxin, by permanently activating the Gs alpha subunit, causes a prolonged increase in cAMP, thereby continuously stimulating TIP20's functionality in the secretory machinery. Adenosine and PACAP bind to their respective receptors to elevate cAMP, thus fostering an environment conducive to TIP20's activity. Meanwhile, Rolipram, by inhibiting phosphodiesterase 4, indirectly contributes to a higher cAMP environment that can aid in TIP20's role in vesicle fusion. Lastly, Anisomycin, despite being a protein synthesis inhibitor, can activate stress-activated protein kinase pathways, which may lead to an environment that necessitates the enhanced activity of TIP20 in adapting vesicular transport systems to manage cellular stress.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, which prevents the breakdown of cAMP. Elevated cAMP levels can enhance the secretory pathway involving SNARE complexes, thereby potentially enhancing the functional activity of TIP20 in vesicle docking and fusion. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, which can lead to increased intracellular cAMP levels through adenylate cyclase activation. Higher cAMP levels may enhance the secretory pathway and thus increase the functional activity of TIP20 by promoting vesicular trafficking and fusion. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) interacts with its G-protein-coupled receptors leading to an increase in cAMP levels within the cell. This upsurge in cAMP can, in turn, stimulate the vesicular transport pathway involving TIP20, thereby enhancing its functional activity in the process of vesicle fusion. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can bind to H2 receptors, which activate adenylate cyclase and increase cAMP levels. Elevated cAMP may indirectly activate TIP20 by stimulating vesicular transport processes in which TIP20 plays a role, thus supporting its functional activity in vesicle docking and fusion. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine, through its interaction with D1-like receptors, can increase intracellular cAMP levels by activating adenylate cyclase. This increase in cAMP may assist in the activation of vesicle trafficking pathways involving TIP20, thereby enhancing its functional role in these processes. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine interacts with A2A receptors, which increases cAMP production via adenylate cyclase activation. Elevated cAMP levels can activate pathways in which TIP20 is involved, enhancing its functional activity in the secretory processes and vesicular fusion. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, leading to an increase in cAMP levels within the cell. The resulting enhancement of the cAMP pathway can indirectly stimulate the vesicular transport system where TIP20 functions, thereby potentially increasing its functional activity in vesicle docking and fusion. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $94.00 $141.00 | ||
Salbutamol activates beta-2 adrenergic receptors, leading to an increase in intracellular cAMP via adenylate cyclase activation. This elevation of cAMP may enhance the vesicular trafficking pathways, thereby contributing to the functional activation of TIP20 in the context of vesicle fusion and membrane trafficking processes. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinase (SAPK) pathways, which could lead to alterations in cellular trafficking processes. Though not a direct activator, the stress response can hypothetically enhance the functional activity of TIP20 by adapting vesicular transport systems to cope with the induced stress. | ||||||